New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction SANTA CLARA, Calif., May 29, 2020 (GLOBE ...
LOS GATOS, CA / ACCESS Newswire / October 21, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device and biologics company with a spine and extremities focus, today announced the U.S. Food and Drug ...
Rockville, April 17, 2023 (GLOBE NEWSWIRE) -- The global sacroiliac joint fusion market is expected to be worth US$ 620 million in 2022 and US$ 3,900 million by 2032. During the projected period of ...
TAMPA, Fla., June 7, 2023 /PRNewswire/ -- The results of a comparative biomechanical analysis of the posterior sacroiliac (SI) joint fusion to the traditional lateral approach show that a posterior SI ...
LOS GATOS, CA / ACCESS Newswire / September 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced ...
DEL MAR, Calif.--(BUSINESS WIRE)--SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, ...
1. Tenon Medical earned FDA 510(k) clearance to use its Catamaran sacroiliac joint system for augmenting thoracolumbar fusion. The indication was first used in June by Andrew Trontis, MD. 2. A new ...
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device and biologics company with a spine and extremities focus, today announced the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results